![S. Rothenberg](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Fortuna: - $ al 31/05/2026
S.
Michael Rothenberg is currently an Independent Director at Tyra Biosciences, Inc. since 2024 and Chief Medical Officer at Insitro, Inc. since 2024.
Formerly, served as Vice President-Research & Development at Loxo Oncology, Inc. from 2015 to 2020.
Education includes undergraduate studies at Yale University and a doctorate from Stanford University School of Medicine.
| Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
|---|---|---|---|---|
TYRA BIOSCIENCE, INC -.--% | 28/05/2026 | 0 ( -.--% ) | - $ | 31/05/2026 |
| Empresas | Cargo | Inicio |
|---|---|---|
| TYRA BIOSCIENCES, INC. | Director/Miembro de la Junta | 07/05/2024 |
Insitro, Inc.
 Insitro, Inc. BiotechnologyHealth Technology Operates as a biology based AI therapeutics company | Director Técnico/Científico/I+D | 01/02/2024 |
| Empresas | Cargo | Fin |
|---|---|---|
| LOXO ONCOLOGY INC | Director Técnico/Científico/I+D | 01/01/2020 |
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
| Empresas privadas | 5 |
|---|---|
Yale University
 Yale University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Loxo Oncology, Inc.
 Loxo Oncology, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that develops medicine for cancer treatment | Health Technology |
Stanford University School of Medicine
 Stanford University School of Medicine Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Insitro, Inc.
Insitro, Inc. BiotechnologyHealth Technology Operates as a biology based AI therapeutics company | Health Technology |
Tyra Biosciences, Inc.
 Tyra Biosciences, Inc. BiotechnologyHealth Technology Operates as a clinical-stage biotechnology company that develops cancer treatment drug therapies | Health Technology |
Selecciona tu edición
Toda la información financiera adaptada al ámbito nacional.
Elige MarketScreener 
